$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
格拉斯吉布薄膜片Glasdegib治疗白血病效果好吗?用多久见效
2025-10-19 11:44:20
Check Details
FDA授予IO-202用于R/R AML的快速通道指定
2025-10-19 11:44:20
Check Details
阿扎胞苷片获批用于缓解期口服维持治疗!
2025-10-19 11:44:20
Check Details
杜韦利西布可以用医保购买吗?有副作用吗?
2025-10-19 11:44:20
Check Details
靶向治疗加化疗为AML获得性耐药提供了解决方法
2025-10-19 11:44:20
Check Details
吉妥单抗gemtuzumab是治疗急性髓性白血病新药
2025-10-19 11:44:20
Check Details
吉妥单抗gemtuzumab多少钱一盒?哪里有卖的
2025-10-19 11:44:20
Check Details
博舒替尼针对TKI治疗的CML患者治疗的有效率达25.9%!
2025-10-19 11:44:20
Check Details
抗癌靶向药物博舒替尼属于第几代靶向药物?有什么作用?
2025-10-19 11:44:20
Check Details
分析发现复发/难治性慢性淋巴细胞白血病患者对BTK抑制剂的耐药性机制
2025-10-19 11:44:20
Check Details
低甲基化药物+维奈克拉片一线治疗继发性急性髓系白血病可提高疗效
2025-10-19 11:44:20
Check Details
FDA授予艾伏尼布/阿扎胞苷优先审查资格,用于IDH1突变型急性髓系白血病
2025-10-19 11:44:20
Check Details
1
2
...
651
652
653
654
655
656
657
...
938
939
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
2
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
3
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
4
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
5
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
6
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
7
Anagrelide and Myelofibrosis Risk: Controversy and Monitoring in ET Treatment
8
Acalabrutinib Dosing Guide: Dosage, Duration and Precautions
9
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
10
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
11
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
12
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights